Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |